rosiglitazone/metformin

DRUG3 trials

Sponsors

GlaxoSmithKline

Conditions

Diabetes Mellitus, Type 2

Phase 3

A Study To Evaluate The Safety And Efficacy Of An Investigational Diabetes Drug In Poorly Controlled Type II Diabetics

CompletedNCT00067951

GlaxoSmithKlineDiabetes Mellitus, Type 2

Start: 2003-10-17End: 2004-11-30Updated: 2018-03-21

Study Of AVANDAMET® With Or Without Insulin In Type II Diabetes Mellitus Patients. AVANDAMET® is a Registered Trademark of the GSK Group of Companies.

CompletedNCT00069836

GlaxoSmithKlineDiabetes Mellitus, Type 2

Start: 2003-10-31End: 2004-11-30Updated: 2016-09-01

Phase 4

AVANDAMET Versus Metformin For Type 2 Diabetes Mellitus

CompletedNCT00241605

GlaxoSmithKlineDiabetes Mellitus, Type 2

Start: 2003-06-25End: 2005-12-16Target: 600Updated: 2018-03-21

Related Papers

How many unpublished studies? ClinicalTrials.gov (n = 2614 studies): diabetes | Closed Studies | Interventional Studies | Phase 3, 4 | Search Date: Oct 27, 2014

Figshare2014-01-01